Source: Annual Congress 2005 - New insights in respiratory infections in children
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Reichenbach, J. Schulze, M. Rose, R. Schubert, S. Zielen (Frankfurt, Germany). Prophylaxis with azithromycin in primary immunodeficiency and bronchiectasis. Eur Respir J 2005; 26: Suppl. 49, 2779

Member's Comments

No comment yet.

Related content which might interest you: Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients Source: Eur Respir J 2002; 20: 28S-39S Year: 2002 Pulmonary disorders and critical care of patients with HIV infection in the era of anti-retrovirals Source: Annual Congress 2006 - MP6 – Pulmonary disorders and critical care of patients with HIV infection in the era of anti-retrovirals Year: 2006 Antibiotic treatment strategies in adults with bronchiectasis Source: Eur Respir Mon 2011; 52: 211-222 Year: 2011 Intrabronchial lymphotropic immune and antibiotic therapy in complex treatment of pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 615s Year: 2002 Humoral immunodeficiency and the lung Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=220 Year: 2005 Pulmonary complications in intravenous drug users with and without human immunodeficiency virus co-infection. Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019 What is the optimal medical therapy for bronchiectasis? Source: Annual Congress 2006 - Up to date management of bronchiectasis Year: 2006 Pulmonary diseases in primary immunodeficiency syndromes Source: Respipedia Article Year: 2017 Current treatments for respiratory infections in children Source: Annual Congress 2005 - PG5 - Paediatrics: respiratory infections in children Year: 2005 The severity of Pneumocystis pneumonia without human immunodeficiency virus infection (non-HIV PCP) might be underestimated by conventional diagnostic rules for community-acquired pneumonia (CAP) Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 The role of adherence in tuberculosis HIV-positive patients treated in ambulatory regimen Source: Eur Respir J 2003; 21: 785-788 Year: 2003 Prevention and treatment of exacerbations of non-CF bronchiectasis Source: Eur Respir Monogr 2013; 60: 127-136 Year: 2013 Antibiotic treatment and prophylaxis Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases Year: 2006 Pulmonary infections in HIV-infected patients: an update in the 21st century Source: Eur Respir J 2012; 39: 730-745 Year: 2012 Efficacy of intravenous immunoglobulin therapy on the incidence of pneumonia in Iranian patients with common variable immunodeficiency Source: Eur Respir J 2004; 24: Suppl. 48, 357s Year: 2004 Lymphotropic therapy of community acquired pneumonias associated with pulmonary destruction Source: Eur Respir J 2006; 28: Suppl. 50, 166s Year: 2006 The use of antiviral drug Ribavirin in cases of viral-bacterial community acquired pneumonia Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018 Corticosteroids as adjunctive therapy in tuberculosis pneumonia with ART Source: Breathe 2008; 5: 274 Year: 2009 Pneumococcal pneumonia: an old disease with radically-new approaches for antibiotic therapy Source: Annual Congress 2005 - Outcome in severe pneumonia Year: 2005